Metabolic-flux and body-composition rodent research models
HGF/c-Met signaling is a well-established oncogenic pathway: c-Met is amplified or overexpressed in multiple cancers (gastric, lung, renal, hepatocellular) HGF/c-Met activation promotes tumor cell proliferation, survival, invasion, and metastasis c-Met inhibitors are FDA-approved cancer drugs (cabozantinib, crizotinib, capmatinib) A compound that potentiates HGF/c-Met signaling raises theoretical concerns about promoting tumor growth or transformation with chronic use
Rarely, mild allergic reactions, temporary redness at the injection site, or light gastrointestinal upset may occur
Product should not be used by pregnant women
Why Researchers Choose PSPeptides US Manufactured: All peptides are synthesized in US-based facilities under strict quality control protocols
The BPC-157 vs TB-500 comparison helps determine which approach suits your specific situation